Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Radiopharmaceuticals Market 

5.1. COVID-19 Landscape: Radiopharmaceuticals Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Radiopharmaceuticals Market, By Radioisotope

8.1. Radiopharmaceuticals Market, by Radioisotope, 2023-2032

8.1.1. Iodine I

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Gallium 68

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Technetium 99m

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Fluorine 18

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Radiopharmaceuticals Market, By Application

9.1. Radiopharmaceuticals Market, by Application, 2023-2032

9.1.1. Cancer

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Cardiology

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Radiopharmaceuticals Market, By Type 

10.1. Radiopharmaceuticals Market, by Type, 2023-2032

10.1.1. Diagnostic

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Therapeutic

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Radiopharmaceuticals Market, By End User 

11.1. Radiopharmaceuticals Market, by End User, 2023-2032

11.1.1. Hospitals and clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Medical Imaging centers

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Radiopharmaceuticals Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.4. Market Revenue and Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Radioisotope (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. Bayer AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Iso-Tex Diagnostics, Inc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Jubilant Pharmova Limited

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Novartis AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. General Electric Company

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Lantheus Holdings, Inc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Eli Lilly and Company

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Siemens AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Curium Pharma

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Cardinal Health Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

 

15.2. Glossary of Terms